<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Center for Public Integrity</provider_name><provider_url>https://publicintegrity.org</provider_url><author_name>admin</author_name><author_url>https://publicintegrity.org/author/admin/</author_url><title>Drugmakers set to gain as taxpayers foot new opioid costs</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="QhgyL5T8jl"&gt;&lt;a href="https://publicintegrity.org/politics/state-politics/drugmakers-set-to-gain-as-taxpayers-foot-new-opioid-costs/"&gt;Drugmakers set to gain as taxpayers foot new opioid costs&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://publicintegrity.org/politics/state-politics/drugmakers-set-to-gain-as-taxpayers-foot-new-opioid-costs/embed/#?secret=QhgyL5T8jl" width="600" height="338" title="&#x201C;Drugmakers set to gain as taxpayers foot new opioid costs&#x201D; &#x2014; Center for Public Integrity" data-secret="QhgyL5T8jl" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
&lt;/script&gt;
</html><thumbnail_url>https://i0.wp.com/publicintegrity.org/wp-content/uploads/2018/10/AP_16271837996563-2.jpg?fit=1260%2C806&amp;ssl=1</thumbnail_url><thumbnail_width>1260</thumbnail_width><thumbnail_height>806</thumbnail_height><description>Critics say the answer pharmaceutical companies are pushing to address the ongoing opioid crisis boosts their profits while forcing taxpayers to shoulder the costs. Some drugmakers aim to replace ubiquitous painkillers such as Vicodin and Percocet with harder-to-abuse formulations that are patent-protected and command higher prices &#x2014; a plan that could cost government-funded health programs [&hellip;]</description></oembed>
